Antara Approval History
- FDA approved: Yes (First approved November 30th, 2004)
- Brand name: Antara
- Generic name: fenofibrate
- Dosage form: Capsules
- Company: Reliant Pharmaceuticals, Inc.
- Treatment for: Hypertriglyceridemia, High Cholesterol, Familial Heterozygous
Antara (fenofibrate) is a lipid-lowering agent approved as adjunctive therapy to diet for the treatment of elevated levels of cholesterol and triglycerides.
Development History and FDA Approval Process for Antara
|Nov 30, 2004||Antara Reliant Pharmaceuticals, Inc. - Treatment for Hypercholesterolemia and Hypertriglyceridemia|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.